Return on Equity (ROE)
Higher than 74% of Healthcare sector peers
Updated 19h ago
Sector Performance
74th percentileAZN
23.5%
Sector Median
8.9%
Sector Avg
30.6%
Deep Analysis
AstraZeneca’s current Return on Equity (
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about AZN?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
How does AZN's Return on Equity (ROE) compare to its sector?
AZN's Return on Equity (ROE) of 23.5% compares to a Healthcare sector median of 8.9%, placing it in the 74th percentile.
Who are AZN's closest peers by Return on Equity (ROE)?
The closest Healthcare peers by Return on Equity (ROE) include: ZBH (6.1%), TECH (5.3%), RVTY (3.2%), BIO (2.5%), BEAM (-5.8%).
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master AZN's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full AZN research report →AZN
23.5%
Sector Median
8.9%
Sector Avg
30.6%
How AZN's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.